Eagle Pharmaceuticals (EGRX) PT Raised to $66 at RBC Capital

March 1, 2019 6:44 AM

RBC Capital analyst Randall Stanicky raised the price target on Eagle Pharmaceuticals (NASDAQ: EGRX) to $66.00 (from $64.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found